2540 related articles for article (PubMed ID: 20840865)
1. Oxidative stress, inflammation, and cancer: how are they linked?
Reuter S; Gupta SC; Chaturvedi MM; Aggarwal BB
Free Radic Biol Med; 2010 Dec; 49(11):1603-16. PubMed ID: 20840865
[TBL] [Abstract][Full Text] [Related]
2. Inflammation and cancer: the oncogene-driven connection.
Borrello MG; Degl'Innocenti D; Pierotti MA
Cancer Lett; 2008 Aug; 267(2):262-70. PubMed ID: 18502035
[TBL] [Abstract][Full Text] [Related]
3. Inflammation and oxidative stress in angiogenesis and vascular disease.
Kim YW; West XZ; Byzova TV
J Mol Med (Berl); 2013 Mar; 91(3):323-8. PubMed ID: 23430240
[TBL] [Abstract][Full Text] [Related]
4. Heat-shock proteins in infection-mediated inflammation-induced tumorigenesis.
Goldstein MG; Li Z
J Hematol Oncol; 2009 Jan; 2():5. PubMed ID: 19183457
[TBL] [Abstract][Full Text] [Related]
5. Regulatory Components of Oxidative Stress and Inflammation and Their Complex Interplay in Carcinogenesis.
Dharshini LCP; Rasmi RR; Kathirvelan C; Kumar KM; Saradhadevi KM; Sakthivel KM
Appl Biochem Biotechnol; 2023 May; 195(5):2893-2916. PubMed ID: 36441404
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis.
Vallée A; Lecarpentier Y
Front Immunol; 2018; 9():745. PubMed ID: 29706964
[TBL] [Abstract][Full Text] [Related]
7. Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405.
Probst BL; McCauley L; Trevino I; Wigley WC; Ferguson DA
PLoS One; 2015; 10(8):e0135257. PubMed ID: 26301506
[TBL] [Abstract][Full Text] [Related]
8. Inflammation: gearing the journey to cancer.
Kundu JK; Surh YJ
Mutat Res; 2008; 659(1-2):15-30. PubMed ID: 18485806
[TBL] [Abstract][Full Text] [Related]
9. IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis.
Bollrath J; Greten FR
EMBO Rep; 2009 Dec; 10(12):1314-9. PubMed ID: 19893576
[TBL] [Abstract][Full Text] [Related]
10. The role of inflammation, oxidative stress, angiogenesis, and apoptosis in the pathophysiology of endometriosis: Basic science and new insights based on gene expression.
Samimi M; Pourhanifeh MH; Mehdizadehkashi A; Eftekhar T; Asemi Z
J Cell Physiol; 2019 Nov; 234(11):19384-19392. PubMed ID: 31004368
[TBL] [Abstract][Full Text] [Related]
11. Chronic inflammation and cancer: the role of the mitochondria.
Kamp DW; Shacter E; Weitzman SA
Oncology (Williston Park); 2011 Apr; 25(5):400-10, 413. PubMed ID: 21710835
[TBL] [Abstract][Full Text] [Related]
12. Luteolin inhibits Cr(VI)-induced malignant cell transformation of human lung epithelial cells by targeting ROS mediated multiple cell signaling pathways.
Pratheeshkumar P; Son YO; Divya SP; Roy RV; Hitron JA; Wang L; Kim D; Dai J; Asha P; Zhang Z; Wang Y; Shi X
Toxicol Appl Pharmacol; 2014 Dec; 281(2):230-41. PubMed ID: 25448439
[TBL] [Abstract][Full Text] [Related]
13. Do all roads lead to the Rome? The glycation perspective!
Ahmad S; Akhter F; Shahab U; Rafi Z; Khan MS; Nabi R; Khan MS; Ahmad K; Ashraf JM; Moinuddin
Semin Cancer Biol; 2018 Apr; 49():9-19. PubMed ID: 29113952
[TBL] [Abstract][Full Text] [Related]
14. Multiple oncogenic roles of nuclear beta-catenin.
Kumar R; Bashyam MD
J Biosci; 2017 Dec; 42(4):695-707. PubMed ID: 29229887
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
16. Multifaceted link between cancer and inflammation.
Sethi G; Shanmugam MK; Ramachandran L; Kumar AP; Tergaonkar V
Biosci Rep; 2012 Feb; 32(1):1-15. PubMed ID: 21981137
[TBL] [Abstract][Full Text] [Related]
17. Heparanase: From basic research to therapeutic applications in cancer and inflammation.
Vlodavsky I; Singh P; Boyango I; Gutter-Kapon L; Elkin M; Sanderson RD; Ilan N
Drug Resist Updat; 2016 Nov; 29():54-75. PubMed ID: 27912844
[TBL] [Abstract][Full Text] [Related]
18. Adaptation to oxidative stress, chemoresistance, and cell survival.
Landriscina M; Maddalena F; Laudiero G; Esposito F
Antioxid Redox Signal; 2009 Nov; 11(11):2701-16. PubMed ID: 19778285
[TBL] [Abstract][Full Text] [Related]
19. The interplay between inflammation and oxidative stress in carcinogenesis.
Nowsheen S; Aziz K; Kryston TB; Ferguson NF; Georgakilas A
Curr Mol Med; 2012 Jul; 12(6):672-80. PubMed ID: 22292435
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting NF-κB activation by small molecules as a therapeutic strategy.
Gupta SC; Sundaram C; Reuter S; Aggarwal BB
Biochim Biophys Acta; 2010; 1799(10-12):775-87. PubMed ID: 20493977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
